Global artificial insemination market set to reach USD 4.29 billion by 2032 due to various factors
From GlobeNewswire: 2025-05-02 08:15:00
The global artificial insemination market is set to reach USD 4.29 billion by 2032, growing at a CAGR of 7.86%. Factors driving this growth include rising infertility rates, advances in reproductive technologies, and increased fertility clinic availability. In the US, the market is expected to reach USD 0.49 billion by 2032, reflecting steady demand influenced by changing lifestyles and greater awareness of fertility treatments.
Couples are increasingly turning to fertility treatments due to changing lifestyles and rising infertility rates, leading to significant growth in the global artificial insemination market. New technologies, growing investments in fertility clinics, and supportive regulatory environments are also contributing to market expansion. In the US, advancements in reproductive healthcare technology and digital solutions are improving patient outcomes and satisfaction, boosting adoption rates of artificial insemination services.
In 2023, the Intrauterine Insemination (IUI) category dominated the global market with a 70.14% share, offering simplicity, accessibility, and higher success rates. The AIH-Husband source category led with a 66.80% market share, while Fertility Clinics & Other Facilities controlled 54.12% of the market. Home Settings are predicted to show the biggest increase, catering to the growing trend of at-home insemination kits for convenience and affordability.
North America led the artificial insemination market in 2023, with Asia-Pacific expected to experience the fastest growth between 2024 and 2032. Recent developments include Vitrolife AB’s acquisition of eFertility, Cook Medical’s launch of the NestVT Vitrification Device, and FUJIFILM Irvine Scientific’s introduction of a new ART culture media line to enhance embryo viability and development. CooperSurgical introduces new insemination catheter for improved sperm distribution, expanding family building options. Global infertility affects 8-12% of couples, with 15% in North America seeking artificial insemination in 2023. Europe accounted for 28% of insemination cycles in 2023, with Asia Pacific projected to reach 35% by 2032. Insurance covered 38% of fertility treatment costs in the US in 2023, with success rates ranging from 10-20%. Newer technologies like sperm washing show promise for higher outcomes.
For more in-depth analysis and insights on the Artificial Insemination Market, check out the detailed report available for purchase. The report includes key points such as market dynamics, utilization rates of procedures by region, donor sperm statistics, costs, technological adoption, competitive landscape, and more. With a focus on providing accurate market data and consumer insights, SNS Insider aims to empower clients to make informed decisions in a rapidly changing world.
Read more at GlobeNewswire: Artificial Insemination Market Size to Hit USD 4.29 Billion